These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 33663616)

  • 1. Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients.
    Kawasuji H; Tsuji Y; Ogami C; Kimoto K; Ueno A; Miyajima Y; Kawago K; Sakamaki I; Yamamoto Y
    BMC Pharmacol Toxicol; 2021 Mar; 22(1):13. PubMed ID: 33663616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reappraisal of Linezolid Dosing in Renal Impairment To Improve Safety.
    Crass RL; Cojutti PG; Pai MP; Pea F
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 10-Year Experience of Therapeutic Drug Monitoring (TDM) of Linezolid in a Hospital-wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients?
    Pea F; Cojutti PG; Baraldo M
    Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):303-308. PubMed ID: 28419737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proactive therapeutic drug monitoring (TDM) may be helpful in managing long-term treatment with linezolid safely: findings from a monocentric, prospective, open-label, interventional study.
    Cojutti PG; Merelli M; Bassetti M; Pea F
    J Antimicrob Chemother; 2019 Dec; 74(12):3588-3595. PubMed ID: 31504570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice: A Review of Linezolid Pharmacokinetics and Pharmacodynamics.
    Rao GG; Konicki R; Cattaneo D; Alffenaar JW; Marriott DJE; Neely M;
    Ther Drug Monit; 2020 Feb; 42(1):83-92. PubMed ID: 31652190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors associated with high linezolid trough plasma concentrations.
    Morata L; De la Calle C; Gómez-Cerquera JM; Manzanedo L; Casals G; Brunet M; Cobos-Trigueros N; Martínez JA; Mensa J; Soriano A
    Expert Opin Pharmacother; 2016 Jun; 17(9):1183-7. PubMed ID: 27156708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients.
    Matsumoto K; Shigemi A; Takeshita A; Watanabe E; Yokoyama Y; Ikawa K; Morikawa N; Takeda Y
    Int J Antimicrob Agents; 2014 Sep; 44(3):242-7. PubMed ID: 25108880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linezolid-Induced Thrombocytopenia in Patients with Renal Impairment: A Case Series, Review and Dose Advice.
    Laarhuis SRE; Kerskes CHM; Nijziel MR; van Wensen RJA; Touw DJ
    Drugs R D; 2024 Mar; 24(1):109-115. PubMed ID: 38480595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linezolid-Associated Thrombocytopenia in Children With Renal Impairment.
    Jones SJ; Nichols KR; DeYoung HL; Cox EG; Knoderer CA
    J Pediatric Infect Dis Soc; 2015 Sep; 4(3):272-5. PubMed ID: 26407433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A standard dose of linezolid puts patients with hepatic impairment at risk of overexposure.
    Liao R; Dong Y; Chen L; Wang T; Li H; Dong H
    Eur J Clin Pharmacol; 2023 Jan; 79(1):149-157. PubMed ID: 36434292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of high plasma concentrations of linezolid in Taiwanese adult patients- therapeutic drug monitoring in improving adverse drug reactions.
    Cheng CN; Wu CC; Kuo CH; Wang CC; Wang JT; Lin YT; Jhang RS; Lin SW
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 2):466-475. PubMed ID: 32600864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initially Reduced Linezolid Dosing Regimen to Prevent Thrombocytopenia in Hemodialysis Patients.
    Kawasuji H; Tsuji Y; Ogami C; Kaneda M; Murai Y; Kimoto K; Ueno A; Miyajima Y; Fukui Y; Sakamaki I; Yamamoto Y
    Antibiotics (Basel); 2021 Apr; 10(5):. PubMed ID: 33925912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic drug monitoring of linezolid and exploring optimal regimens and a toxicity-related nomogram in elderly patients: a multicentre, prospective, non-interventional study.
    Liu T; Yuan Y; Wang C; Wu J; Wang Y; Na P; Chen X; Rao W; Zhao J; Wang D; Wang H; Duan Z; Xie F; Fang X; Xie L; Li H
    J Antimicrob Chemother; 2024 Aug; 79(8):1938-1950. PubMed ID: 38873816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug management of linezolid: a missed opportunity for clinicians?
    Cattaneo D; Gervasoni C; Cozzi V; Castoldi S; Baldelli S; Clementi E
    Int J Antimicrob Agents; 2016 Dec; 48(6):728-731. PubMed ID: 27769709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linezolid dose adjustment according to therapeutic drug monitoring helps reach the goal concentration in severe patients, and the oldest seniors benefit more.
    Xu Y; Yang X; Liang P; Qu C
    BMC Infect Dis; 2023 Nov; 23(1):840. PubMed ID: 38030977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosage regimen and toxicity risk assessment of linezolid in sepsis patients.
    Dou L; Meng D; Dong Y; Chen L; Han X; Fan D; Dong H
    Int J Infect Dis; 2020 Jul; 96():105-111. PubMed ID: 32251797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia.
    Nukui Y; Hatakeyama S; Okamoto K; Yamamoto T; Hisaka A; Suzuki H; Yata N; Yotsuyanagi H; Moriya K
    J Antimicrob Chemother; 2013 Sep; 68(9):2128-33. PubMed ID: 23625638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult Patients.
    Cojutti P; Pai MP; Pea F
    Clin Pharmacokinet; 2018 Aug; 57(8):989-1000. PubMed ID: 29080937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Drug Monitoring Coupled With Bayesian Forecasting Could Prevent Vancomycin-Associated Nephrotoxicity in Renal Insufficiency Patients: A Prospective Study and Pharmacoeconomic Analysis.
    Zhang Y; Wang T; Zhang D; You H; Dong Y; Liu Y; Du Q; Sun D; Zhang T; Dong Y
    Ther Drug Monit; 2020 Aug; 42(4):600-609. PubMed ID: 32097248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients.
    Pea F; Viale P; Cojutti P; Del Pin B; Zamparini E; Furlanut M
    J Antimicrob Chemother; 2012 Aug; 67(8):2034-42. PubMed ID: 22553142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.